CGEM
Price
$7.75
Change
+$0.25 (+3.33%)
Updated
Apr 2, 02:45 PM (EDT)
Capitalization
438.85M
48 days until earnings call
ORMP
Price
$2.19
Change
+$0.06 (+2.82%)
Updated
Apr 2, 04:59 PM (EDT)
Capitalization
85.86M
56 days until earnings call
Ad is loading...

CGEM vs ORMP

Header iconCGEM vs ORMP Comparison
Open Charts CGEM vs ORMPBanner chart's image
Cullinan Therapeutics
Price$7.75
Change+$0.25 (+3.33%)
Volume$200
Capitalization438.85M
Oramed Pharmaceuticals
Price$2.19
Change+$0.06 (+2.82%)
Volume$506
Capitalization85.86M
CGEM vs ORMP Comparison Chart
Loading...
CGEM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CGEM vs. ORMP commentary
Apr 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGEM is a Buy and ORMP is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 02, 2025
Stock price -- (CGEM: $7.50 vs. ORMP: $2.13)
Brand notoriety: CGEM and ORMP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGEM: 142% vs. ORMP: 31%
Market capitalization -- CGEM: $438.85M vs. ORMP: $85.86M
CGEM [@Biotechnology] is valued at $438.85M. ORMP’s [@Biotechnology] market capitalization is $85.86M. The market cap for tickers in the [@Biotechnology] industry ranges from $302.51B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGEM’s FA Score shows that 1 FA rating(s) are green whileORMP’s FA Score has 0 green FA rating(s).

  • CGEM’s FA Score: 1 green, 4 red.
  • ORMP’s FA Score: 0 green, 5 red.
According to our system of comparison, CGEM is a better buy in the long-term than ORMP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGEM’s TA Score shows that 4 TA indicator(s) are bullish while ORMP’s TA Score has 3 bullish TA indicator(s).

  • CGEM’s TA Score: 4 bullish, 4 bearish.
  • ORMP’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, CGEM is a better buy in the short-term than ORMP.

Price Growth

CGEM (@Biotechnology) experienced а -9.64% price change this week, while ORMP (@Biotechnology) price change was -8.58% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.91%. For the same industry, the average monthly price growth was -7.11%, and the average quarterly price growth was -11.65%.

Reported Earning Dates

CGEM is expected to report earnings on May 20, 2025.

ORMP is expected to report earnings on May 28, 2025.

Industries' Descriptions

@Biotechnology (-4.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CGEM($439M) has a higher market cap than ORMP($85.9M). ORMP YTD gains are higher at: -11.983 vs. CGEM (-38.424). ORMP has higher annual earnings (EBITDA): 9.44M vs. CGEM (-196.61M). CGEM has more cash in the bank: 399M vs. ORMP (142M). ORMP has less debt than CGEM: ORMP (429K) vs CGEM (2.15M). CGEM (0) and ORMP (0) have equivalent revenues.
CGEMORMPCGEM / ORMP
Capitalization439M85.9M511%
EBITDA-196.61M9.44M-2,083%
Gain YTD-38.424-11.983321%
P/E RatioN/A20.91-
Revenue00-
Total Cash399M142M281%
Total Debt2.15M429K501%
FUNDAMENTALS RATINGS
ORMP: Fundamental Ratings
ORMP
OUTLOOK RATING
1..100
82
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
85
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
42
SEASONALITY SCORE
1..100
13

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CGEMORMP
RSI
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
73%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 22 days ago
72%
Bullish Trend 27 days ago
82%
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
77%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
85%
View a ticker or compare two or three
Ad is loading...
CGEM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JMCRX19.31N/A
N/A
James Micro Cap
NDXKX34.12N/A
N/A
Shelton Nasdaq-100 Index K
TWGGX10.60N/A
N/A
American Century Focused Global Gr Inv
HILYX20.45N/A
N/A
Hartford International Value Y
BHCFX18.48N/A
N/A
Baron Health Care Retail

CGEM and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGEM has been loosely correlated with MDGL. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if CGEM jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGEM
1D Price
Change %
CGEM100%
-0.92%
MDGL - CGEM
50%
Loosely correlated
-2.19%
GOSS - CGEM
45%
Loosely correlated
-9.61%
ORMP - CGEM
42%
Loosely correlated
-0.47%
DNLI - CGEM
38%
Loosely correlated
-9.60%
ABOS - CGEM
38%
Loosely correlated
-2.27%
More